An Analysis of Serum Interleukin-6 Levels to Predict Benefits of Medroxyprogesterone Acetate in Advanced or Recurrent Breast Cancer

Reiki Nishimura,Kazuharu Nagao,Haruhiko Miyayama,Masakazu Matsuda,Kenichirou Baba,Yukio Matsuoka,Hiroya Yamashita,Makoto Fukuda,Takao Mizumoto,Rieko Hamamoto

An Analysis of Serum Interleukin-6 Levels to Predict Benefits of Medroxyprogesterone Acetate in Advanced or Recurrent Breast Cancer

2000

Reiki Nishimura
Kazuharu Nagao
Haruhiko Miyayama
Masakazu Matsuda
Kenichirou Baba
Yukio Matsuoka
Hiroya Yamashita
Makoto Fukuda
Takao Mizumoto
Rieko Hamamoto

Treatment of advanced or recurrent breast cancer with medroxyprogesterone acetate (MPA) shows high response rates and the accessory effects of appetite stimulation, improvement in performance status (

Keywords:

Immunology
Breast cancer
Prospective cohort study
Mammary gland
Medroxyprogesterone
Cancer
Performance status
Medicine
Interleukin 6
Medroxyprogesterone acetate
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations